Credit Suisse »

Allogene Therapeutics shares owned by Credit Suisse

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Credit Suisse from 13F filings

Historical chart of Credit Suisse investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Credit Suisse

Quarter filed Position value Share count Share price at filing
2023-12-31 $245k 76k 3.21
2023-09-30 $270k 85k 3.17
2023-06-30 $594k 120k 4.97
2023-03-31 $523k 106k 4.94
2022-12-31 $644k 102k 6.29
2022-09-30 $891k 82k 10.82
2022-06-30 $929k 81k 11.42
2022-03-31 $617k 68k 9.13
2021-12-31 $965k 65k 14.93
2021-09-30 $2.0M 78k 25.66
2021-06-30 $1.9M 74k 26.08
2021-03-31 $2.2M 62k 35.30
2020-12-31 $2.3M 132k 17.54
2020-09-30 $3.1M 116k 27.03
2020-06-30 $5.2M 122k 42.82
2020-03-31 $1.4M 74k 19.48
2019-12-31 $3.4M 130k 25.99
2019-09-30 $964k 19k 50.00
2019-06-30 $375k 14k 26.86